Bausch Health Companies | DEBITO



Debt Cambiamento Data
Amgen USD 56.2B 1.18B 2025-06
ANI Pharmaceuticals USD 621.56M 1.26M 2025-06
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.74B 228M 2025-06
Biogen USD 6.59B 296.8M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Danaher USD 17.36B 878M 2025-06
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 39.9B 1.39B 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Novo Nordisk 118.72B 61.75B 2025-03
Pacira USD 580.49M 2.88M 2025-06
Perrigo USD 3.65B 24.4M 2025-06
Prestige Brands USD 1.04B 27.25M 2025-06
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06
Zoetis USD 6.79B 214M 2025-06


Bausch Health Companies DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.